The CIN framework assigns Charlotte's Web Holdings a Neutral rating at 44/100, with conviction of 2 out of 5. The composite is a fixed blend of four pillars — fundamentals at 35 percent, regulatory at 25, market at 25, and editorial at 15 — and each contribution is inspectable. The strongest contribution comes from the fundamentals pillar at 50, and pulls the composite toward the lower edge of the band. Editorial lags at 30, softening what would otherwise be a stronger reading.
Under the hood, the data points sit as follows: reported revenue growth of -9.0 percent year over year, an operating margin of -38.8 percent, gross margin of 42.4 percent. Each of those figures ties back to a specific input in the pillar breakdown. Every input flowing into the pillar table comes from primary regulatory filings, licensed fundamentals data, and institutional pricing feeds, filtered through CIN newsroom density. The 336-ticker CIN universe is scored deterministically, so Charlotte's Web Holdings can be compared against the US operator peer set on identical inputs, refreshed on the ingest cycle.
The forward path is set by fundamentals, which carry 50 of this rating. A quarterly print showing revenue above the trailing four-quarter run rate — paired with a defensible operating margin — would justify a tighter band; the reverse would loosen it.
Bullish and Bearish Analyst Opinions for Charlotte's Web Holdings (CWBHF)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Charlotte's Web Holdings (CWBHF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
Bullish and bearish analyst opinions for Charlotte's Web Holdings (CWBHF)
Bullish view. Charlotte's Web is one of the best-known CBD brands in North America with strong DTC and mass-retail distribution; bulls model any FDA action on CBD as dietary supplement as a step-change catalyst for the whole category, with Charlotte's Web positioned as the brand-share leader.
Bearish view. Bears cite persistent CBD-category revenue declines, cash-flow pressure, and dependence on future FDA rulemaking that has been stalled for years without resolution.
5-year weekly price history, intraday quotes, and 52-week range for CWBHF are maintained by Cannabis Investor News and refreshed throughout the trading day.